Cataract after busulphan treatment.
作者信息
Ravindranathan M P, Paul V J, Kuriakose E T
出版信息
Br Med J. 1972 Jan 22;1(5794):218-9. doi: 10.1136/bmj.1.5794.218.
Abstract
摘要
相似文献
1
Cataract after busulphan treatment.
Br Med J. 1972 Jan 22;1(5794):218-9. doi: 10.1136/bmj.1.5794.218.
2
Cataract after busulphan therapy.白消安治疗后的白内障。
Acta Haematol. 1986;76(4):236. doi: 10.1159/000206064.
3
[Busulfan and eye complications].[白消安与眼部并发症]
Duodecim. 1985;101(24):2420-2.
4
Cataract after prolonged busulphan therapy.长期白消安治疗后出现白内障。
Acta Haematol. 1993;90(4):213. doi: 10.1159/000204467.
5
Clinical and morphological side-effects of busulfan (Myleran) treatment.白消安（马利兰）治疗的临床及形态学副作用
Acta Med Scand. 1972 Jul-Aug;192(1-2):129-35. doi: 10.1111/j.0954-6820.1972.tb04789.x.
6
Histopathology and ultrastructure of busulfan-induced cataract.白消安诱导性白内障的组织病理学与超微结构
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976 Aug 30;200(2):139-47. doi: 10.1007/BF00414363.
7
Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy.慢性粒细胞白血病中的晶状体变化。与化疗的可能关系。
Am J Ophthalmol. 1969 Sep;68(3):500-4. doi: 10.1016/0002-9394(69)90722-3.
8
Jaundice after treatment of leukemia with busulphan.白消安治疗白血病后出现的黄疸。
Br Med J. 1971 Mar 6;1(5748):556-7. doi: 10.1136/bmj.1.5748.556-b.
9
Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.使用白消安治疗慢性粒细胞白血病后出现的胆汁淤积性黄疸。
J Clin Pathol. 1970 Dec;23(9):827. doi: 10.1136/jcp.23.9.827-b.
10
Busulphan lung in childhood.儿童白消安肺
J Clin Pathol. 1981 May;34(5):495-500. doi: 10.1136/jcp.34.5.495.
引用本文的文献
1
Risks of cataract surgery in solid and hematologic cancer survivors.实体癌和血液系统癌症幸存者白内障手术的风险
Sci Rep. 2025 Aug 18;15(1):30263. doi: 10.1038/s41598-025-16229-5.
2
Ocular complications in a young pediatric population following bone marrow transplantation.骨髓移植后年轻儿科人群中的眼部并发症
J AAPOS. 2018 Apr;22(2):102-106.e1. doi: 10.1016/j.jaapos.2017.10.010. Epub 2018 Jan 5.
3
Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.白消安处理小鼠慢性骨髓再生障碍模型的进一步发展
Int J Exp Pathol. 2006 Feb;87(1):49-63. doi: 10.1111/j.0959-9673.2006.00455.x.
4
The role of busulfan in bone marrow transplantation.白消安在骨髓移植中的作用。
Med Oncol. 1999 Sep;16(3):166-76. doi: 10.1007/BF02906128.
5
Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.膦甲酸钠用于骨髓移植后巨细胞病毒性视网膜炎的治疗。
Postgrad Med J. 1988 May;64(751):389-91. doi: 10.1136/pgmj.64.751.389.
6
Histopathology and ultrastructure of busulfan-induced cataract.白消安诱导性白内障的组织病理学与超微结构
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976 Aug 30;200(2):139-47. doi: 10.1007/BF00414363.
本文引用的文献
1
Ocular involvement in leukemia and allied disorders.白血病及相关疾病的眼部受累情况。
Arch Ophthalmol. 1961 Oct;66:490-508. doi: 10.1001/archopht.1961.00960010492010.
2
The lens epithelium in the pathogenesis of cataract; the XIII Edward Jackson Memorial lecture.晶状体上皮细胞在白内障发病机制中的作用；第十三届爱德华·杰克逊纪念讲座
Am J Ophthalmol. 1957 Aug;44(2):159-70. doi: 10.1016/0002-9394(57)90001-6.
3
Myleran in chronic myeloid leukaemia; results of treatment.马利兰治疗慢性粒细胞白血病的疗效
Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.
4
Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy.慢性粒细胞白血病中的晶状体变化。与化疗的可能关系。
Am J Ophthalmol. 1969 Sep;68(3):500-4. doi: 10.1016/0002-9394(69)90722-3.
Zotero 插件